Physician profile
John J Green
NPI 1326282864
$8,426.01
in general payments reported to CMS, 2019-2025
38 companies · $431 in 2025
The $431 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,261 · 2020: $518 · 2021: $1,271 · 2022: $1,589 · 2023: $1,861 · 2024: $1,495 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,787.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $885.66 | 2019-2024 | Xarelto |
| Amgen INC. | $806.48 | 2019-2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $802.56 | 2019-2025 | |
| Pfizer INC. | $661.01 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $641.89 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $558.20 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $546.65 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $483.11 | 2019-2025 | Watchman Flx, Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $394.90 | 2019-2025 | Farxiga, Lokelma |
| Amarin Pharma, INC. | $357.82 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $356.15 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $307.48 | 2019-2025 | Lifevest |
| Astellas Pharma US INC | $191.45 | 2019-2022 | |
| Novo Nordisk INC | $178.63 | 2021-2025 | Ozempic, Rybelsus |
| Esperion Therapeutics, INC. | $150.78 | 2021-2024 | Nexletol |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $118.85 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $108.27 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Regeneron Healthcare Solutions, INC. | $105.64 | 2019-2024 | Evkeeza |
| Medtronic, INC. | $84.29 | 2022-2024 | Attain Command + Surevalve, Linq II |
| Edwards Lifesciences Corporation | $77.39 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Arbor Pharmaceuticals, INC. | $72.10 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.85 | 2021-2022 | |
| Portola Pharmaceuticals, LLC | $62.07 | 2019-2020 | |
| Althera Pharmaceuticals LLC | $49.37 | 2021 | |
| Philips North America LLC | $48.82 | 2020-2023 | |
| Abbott Laboratories | $43.99 | 2019-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Kowa Pharmaceuticals America, INC. | $36.22 | 2021 | |
| Impulse Dynamics (USA) INC. | $33.87 | 2020-2024 | Optimizer |
| Daiichi Sankyo INC. | $28.60 | 2024 | Injectafer |
| Baxter Healthcare | $23.69 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Braemar Manufacturing, LLC | $22.18 | 2019 | |
| Lundbeck LLC | $21.88 | 2021 | |
| Ethicon US, LLC | $21.15 | 2022 | |
| Davol INC. | $18.91 | 2021 | |
| Biogen, INC. | $18.02 | 2024 | Skyclarys |
| Globus Medical, INC. | $16.78 | 2025 | Senza |
| Biotronik INC. | $15.71 | 2019 | |
| Medtronic Vascular, INC. | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.